- Filed
- Nov 25, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Nov 18, 2025 | 371.92M sh |
| Shares Diluted | Q3 2025 · Nov 1, 2025 | 380M sh |
| Shares Diluted | Q3 2025 · Nov 1, 2025 | 382M sh |
| Shares Diluted | Q3 2025 · Nov 2, 2024 | 383M sh |
| Shares Diluted | Q3 2025 · Nov 2, 2024 | 383M sh |
| Stock Repurchased | Q3 2025 · Nov 1, 2025 | $152M |
| Stock Repurchased | Q3 2025 · Nov 2, 2024 | $0 |
| Dividends Paid | Q3 2025 · Nov 1, 2025 | $185M |
| Dividends Paid | Q3 2025 · Nov 2, 2024 | $169M |
| Capex | Q3 2025 · Nov 1, 2025 | $327M |
| Capex | Q3 2025 · Nov 2, 2024 | $330M |
| Operating Cash Flow | Q3 2025 · Nov 1, 2025 | $607M |
| Operating Cash Flow | Q3 2025 · Nov 2, 2024 | $870M |
| Long Term Debt | Q3 2025 · Nov 1, 2025 | $1.49B |
| Long Term Debt | Q3 2025 · Feb 1, 2025 | $1.49B |
| Long Term Debt | Q3 2025 · Nov 2, 2024 | $1.49B |
| Short Term Investments | Q3 2025 · Nov 1, 2025 | $255M |
| Short Term Investments | Q3 2025 · Feb 1, 2025 | $253M |
| Short Term Investments | Q3 2025 · Nov 2, 2024 | $250M |
| Cash And Equivalents | Q3 2025 · Nov 1, 2025 | $2.26B |
| Cash And Equivalents | Q3 2025 · Feb 1, 2025 | $2.34B |
| Cash And Equivalents | Q3 2025 · Nov 2, 2024 | $1.97B |
| Stockholders Equity | Q3 2025 · Nov 1, 2025 | $3.65B |
| Stockholders Equity | Q3 2025 · Aug 2, 2025 | $3.43B |
| Stockholders Equity | Q3 2025 · Feb 1, 2025 | $3.26B |
| Stockholders Equity | Q3 2025 · Nov 2, 2024 | $3.14B |
| Stockholders Equity | Q3 2025 · Aug 3, 2024 | $2.9B |
| Stockholders Equity | Q3 2025 · Feb 3, 2024 | $2.6B |
| Current Liabilities | Q3 2025 · Nov 1, 2025 | $3.28B |
| Current Liabilities | Q3 2025 · Feb 1, 2025 | $3.26B |
| Current Liabilities | Q3 2025 · Nov 2, 2024 | $3.33B |
| Current Assets | Q3 2025 · Nov 1, 2025 | $5.64B |
| Current Assets | Q3 2025 · Feb 1, 2025 | $5.2B |
| Current Assets | Q3 2025 · Nov 2, 2024 | $5.13B |
| Total Assets | Q3 2025 · Nov 1, 2025 | $12.37B |
| Total Assets | Q3 2025 · Feb 1, 2025 | $11.89B |
| Total Assets | Q3 2025 · Nov 2, 2024 | $11.85B |
| Eps Diluted | Q3 2025 · Nov 1, 2025 | $0.62 |
| Eps Diluted | Q3 2025 · Nov 1, 2025 | $1.69 |
| Eps Diluted | Q3 2025 · Nov 2, 2024 | $0.72 |
| Eps Diluted | Q3 2025 · Nov 2, 2024 | $1.67 |
| Eps Basic | Q3 2025 · Nov 1, 2025 | $0.63 |
| Eps Basic | Q3 2025 · Nov 1, 2025 | $1.73 |
| Eps Basic | Q3 2025 · Nov 2, 2024 | $0.73 |
| Eps Basic | Q3 2025 · Nov 2, 2024 | $1.70 |
| Net Income | Q3 2025 · Nov 1, 2025 | $236M |
| Net Income | Q3 2025 · Nov 1, 2025 | $645M |
| Net Income | Q3 2025 · Nov 2, 2024 | $274M |
| Net Income | Q3 2025 · Nov 2, 2024 | $638M |
| Operating Income | Q3 2025 · Nov 1, 2025 | $334M |
| Operating Income | Q3 2025 · Nov 1, 2025 | $886M |
| Operating Income | Q3 2025 · Nov 2, 2024 | $355M |
| Operating Income | Q3 2025 · Nov 2, 2024 | $853M |
| Gross Profit | Q3 2025 · Nov 1, 2025 | $1.67B |
| Gross Profit | Q3 2025 · Nov 1, 2025 | $4.65B |
| Gross Profit | Q3 2025 · Nov 2, 2024 | $1.64B |
| Gross Profit | Q3 2025 · Nov 2, 2024 | $4.62B |
| Cost Of Revenue | Q3 2025 · Nov 1, 2025 | $2.27B |
| Cost Of Revenue | Q3 2025 · Nov 1, 2025 | $6.48B |
| Cost Of Revenue | Q3 2025 · Nov 2, 2024 | $2.19B |
| Cost Of Revenue | Q3 2025 · Nov 2, 2024 | $6.32B |
| Revenue | Q3 2025 · Nov 1, 2025 | $3.94B |
| Revenue | Q3 2025 · Nov 1, 2025 | $11.13B |
| Revenue | Q3 2025 · Nov 2, 2024 | $3.83B |
| Revenue | Q3 2025 · Nov 2, 2024 | $10.94B |